Sat-18-07-2020, 21:22 PM
In Cosentyx Lilly had set itself a low bar; cross-trial comparisons suggest that two rival anti-IL-23s, Abbvie’s Skyrizi and Johnson & Johnson’s Tremfya, would have been harder for mirikizumab to beat.
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study
|
« Next Oldest | Next Newest »
|
Messages In This Thread |
Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-17-07-2020, 20:43 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by jiml - Fri-17-07-2020, 21:14 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by JohnB - Sat-18-07-2020, 20:54 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Sun-19-07-2020, 11:25 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 06:10 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 11:41 AM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Caroline - Fri-24-07-2020, 12:04 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by Fred - Fri-24-07-2020, 12:07 PM
RE: Mirikizumab Superior to Cosentyx in phase 3 psoriasis study - by D Foster - Sat-18-07-2020, 21:22 PM
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
![]() |
Zoryve for psoriasis phase 3 results | Fred | 3 | 597 |
Wed-11-06-2025, 14:16 PM Last Post: Fred |
![]() |
Picankibart for psoriasis phase 3 study | Fred | 1 | 332 |
Fri-30-05-2025, 01:03 AM Last Post: mataribot |
![]() |
Cosentyx 9 year psoriasis patient study | Fred | 0 | 292 |
Sun-25-05-2025, 11:07 AM Last Post: Fred |
![]() |
Phase I trial of ASC50 for psoriasis | Fred | 0 | 413 |
Thu-22-05-2025, 12:13 PM Last Post: Fred |
![]() |
ORKA-002 for psoriasis phase 1 started | Fred | 0 | 276 |
Wed-21-05-2025, 13:21 PM Last Post: Fred |